These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 773530

  • 1. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
    Dubois JB, Serrou B.
    Cancer Res; 1976 May; 36(5):1731-4. PubMed ID: 773530
    [Abstract] [Full Text] [Related]

  • 2. Unanticipated effect of BCG in mice treated by radiotherapy.
    Serrou B, Dubois JB.
    Dev Biol Stand; 1976 May; 38():369-72. PubMed ID: 344099
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA, Kleinerman J, Saidel GM.
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [Abstract] [Full Text] [Related]

  • 4. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J.
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG, Peters LC.
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [Abstract] [Full Text] [Related]

  • 6. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.
    Shapiro A, Ratliff TL, Oakley DM, Catalona WJ.
    Cancer Res; 1983 Apr; 43(4):1611-5. PubMed ID: 6339040
    [Abstract] [Full Text] [Related]

  • 7. Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer.
    Bennett JA, Gruft H, McKneally MF, Zelterman D, Crispen RG.
    Cancer Res; 1983 Sep; 43(9):4183-90. PubMed ID: 6347367
    [Abstract] [Full Text] [Related]

  • 8. Bacillus Calmette-Guérin and antilymphocyte serum in carcinogenesis. Effects on the hamster pouch.
    Giunta JL, Reif AE, Shklar G.
    Arch Pathol; 1974 Oct; 98(4):237-40. PubMed ID: 4606260
    [No Abstract] [Full Text] [Related]

  • 9. A cytokinetic analysis of bacillus calmette-guérin-induced growth control of a murine leukemia.
    Olsson L, Mathé G.
    Cancer Res; 1977 Jun; 37(6):1743-9. PubMed ID: 322860
    [Abstract] [Full Text] [Related]

  • 10. Effects of methanol extraction residue and therapeutic irradiation against established isografts and simulated local recurrence of mammary carcinomas.
    Yron I, Cohen D, Robinson E, Haber M, Weiss DW.
    Cancer Res; 1975 Jul; 35(7):1779-90. PubMed ID: 1093676
    [Abstract] [Full Text] [Related]

  • 11. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
    Yarkoni E, Ashley MP, Zbar B, Sugimoto T, Rapp HJ.
    Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
    [Abstract] [Full Text] [Related]

  • 12. [Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor].
    Shiio T, Ohishi K, Tsuchiya Y, Niitsu I, Hayashibara H, Yoshihama T, Moriyuki H.
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):475-9. PubMed ID: 3348633
    [Abstract] [Full Text] [Related]

  • 13. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B, Taylor S, Levine M, Saffer E, Fisher ER.
    Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract] [Full Text] [Related]

  • 14. Failure of Bacillus Calmette-Guérin (BCG) infection to suppress the growth of transplanted mouse and rat sarcomas.
    Símová J, Bubeník J.
    Folia Biol (Praha); 1973 Jul; 19(4):296-300. PubMed ID: 4356560
    [No Abstract] [Full Text] [Related]

  • 15. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP, Tangen CM, Sucharew H, Wood D, Crawford ED.
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [Abstract] [Full Text] [Related]

  • 16. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
    Kreider JW, Bartlett GL, Boyer CM, Purnell DM.
    Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
    [Abstract] [Full Text] [Related]

  • 17. Effect of Bacillus Calmette-Guérin on the development of primary lung cancer in Syrian golden hamsters.
    Zwilling BS, Davis GW.
    Cancer Res; 1980 Oct; 40(10):3455-8. PubMed ID: 7002286
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of tumor growth following immunization with Bacillus Calmette-Guérin cell walls.
    Wepsic HT, Harris S, Sander J, Alaimo J, Morris H.
    Cancer Res; 1976 Jun; 36(6):1950-3. PubMed ID: 178437
    [Abstract] [Full Text] [Related]

  • 19. Oral bacille Calmette Guérin immunostimulation in malignant melanoma.
    MacGregor AB, Falk RE, Landi S, Ambus U, Langer B.
    Surg Gynecol Obstet; 1975 Nov; 141(5):747-54. PubMed ID: 1105837
    [Abstract] [Full Text] [Related]

  • 20. Bacillus Calmette-Guerin in the treatment of neoplastic disease.
    Laucius JF, Bodurtha AJ, Mastrangelo MJ, Creech RH.
    J Reticuloendothel Soc; 1974 Dec; 16(6):347-73. PubMed ID: 4616079
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.